Navigating Israel's 70 & 120-Day Fast-Track Drug Approvals

DDReg Knowledge Capsule · Nov 6, 2026 · 26m

In this episode, we break down the Israel Ministry of Health (MOH) 2025 Drug Registration Reform and what foreign pharmaceutical companies must know to successfully enter the Israeli market. We examine the 70-day and 120-day reliance evaluation pathways, detailing how prior authorisations from recognised foreign regulatory agencies (such as the FDA, EMA, MHRA, Health Canada, and TGA) can streamline registration timelines.

For more info read our blog: https://resource.ddregpharma.com/blogs/drug-registration-israel-foreign-companies/